What Data Says About Biologics-Related Ex Parte Challenges

Recent patent-owner-friendly rule changes to the Patent Trial and Appeal Board's inter partes review and postgrant review procedures may hinder future challenges, inducing petitioners to consider an alternative procedure, ex parte...

Already a subscriber? Click here to view full article